Creatinine Assay Kits Market - Emerging Industry Trends & Future Growth Prospects

The global creatinine assay kits market is expected to reach USD 245.4 Million by 2022 from USD 189.6 Million in 2017, at a CAGR of 5.3%. 

Increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders are the key drivers of the global creatinine assay kits market.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73499229

Based on type of sample, the blood/serum segment is expected to register the highest CAGR during the forecast period

Based on type of sample, the creatinine assay kits market is segmented into blood/serum, urine, and other samples. Other samples mainly include saliva, cerebrospinal fluid, tissue homogenate, and sweat. The blood/serum segment is expected to witness the highest CAGR over the forecast period. Most newly developed creatinine measurement kits are based on the analysis of creatinine in blood samples owing to its accuracy in inferring creatinine concentration. These are the major factors responsible for the increasing adoption of this sample type.

Target Audience for this Report:

# Creatinine assay kit manufacturers
# Creatinine assay kit distributors
# Hospitals
# Research and consulting firms
# Venture capitalists
# Regulatory bodies
# Academic centers
# Teaching hospitals and academic medical centers (AMCs)
# Contract manufacturing organizations (CMOs)
# Contract research organizations (CROs)

In 2017, North America dominated the creatinine assay kits market

In 2017, North America dominated the market followed by Europe. The large share of North America is attributed to factors such as increasing incidence of renal disorders, rising prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction), and the implementation of favorable government initiatives to increase awareness of and encourage research pertaining to kidney diseases.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=73499229

Agreements, acquisitions, and expansions accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. 

The creatinine assay kits market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include Thermo Fisher Scientific (US), Merck (Germany), Abbott Laboratories (US), Abcam (UK), Quidel (US), Enzo Life Sciences (US), Cayman Chemical (US), Crystal Chem (US), Cell Biolabs (US), Genway Biotech (US), BioAssay Systems (US), Wako Pure Chemical Industries (Japan), Tulip Diagnostics (India), BioVision (US), and Arbor Assays (US).